NCT01231373 - Polidocanol Endovenous Microfoam (PEM) Versus Vehicle for the Treatment of Saphenofemoral Junction (SFJ) Incompetence | Biotech Hunter

Enrollment

235

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

August 31, 2014

Conditions

Varicose Veins

Interventions

DRUG

polidocanol injectable foam, 0.125%

active placebo for blinding

DRUG

polidocanol injectable foam, 0.5%

0.5% polidocanol foam injection

DRUG

polidocanol injectable foam, 1.0%

1.0% polidocanol foam injection

DRUG

Vehicle

injection of vehicle comparator

Trial Locations (12)

15143

Monroeville

15232

Pittsburgh

21030

Hunt Valley

21701

Frederick

29615

Greenville

36303

Dothan

47905

Lafayette

73104

Oklahoma City

87544

Los Alamos

92120

San Diego

92121

San Diego

98004

Bellevue